{"entity":{"id":"cancer-discovery","kind":"journal","name":"Cancer Discovery","aka":["Cancer Discov","src-cancer-discovery"],"tldr":"AACR's high-profile journal bridging discovery and the clinic: first-in-human targeted-therapy data, resistance mechanisms and translational biology.","summary":"Cancer Discovery has appeared monthly since 2011 and publishes early clinical results with deep correlative science (KRAS, menin, and other targeted agents' first reports), mechanisms of acquired resistance, and the AACR Cancer Progress Report coverage. Hybrid access; AACR annual meeting plenary papers frequently appear here.","asOf":"2026-09-09","links":[{"label":"AACR","url":"https://www.aacr.org"}],"tags":[],"related":["src-aacr-annual","blood-cancer-discovery"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["aacr"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Holds: High-impact translational and early-clinical science, plus In the Spotlight pieces and news digests of the field. Access: Paywalled; news free."],"publisher":"American Association for Cancer Research","url":"https://aacrjournals.org/cancerdiscovery","issn":"2159-8274","scope":"basic cancer biology","access":"hybrid","founded":2011,"impactFactor":{"value":29.7,"year":2023,"source":"Clarivate Journal Citation Reports 2024 (2023 JIF)"},"matchNames":["Cancer Discovery","Cancer Discov"],"society":"American Association for Cancer Research"},"route":"/journals/cancer-discovery/","neighbours":{"collection":[{"id":"src-aacr-annual","kind":"collection","name":"AACR Annual Meeting","route":"/collections/src-aacr-annual/"}],"journal":[{"id":"blood-cancer-discovery","kind":"journal","name":"Blood cancer discovery","route":"/journals/blood-cancer-discovery/"}],"institution":[{"id":"aacr","kind":"institution","name":"American Association for Cancer Research (AACR)","route":"/institutions/aacr/"}],"paper":[{"id":"paper-bertotti-xenopatients-her2-cetuximab-resistant-colorectal-cancer-discov-2011","kind":"paper","name":"A molecularly annotated platform of patient-derived xenografts identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer","route":"/key-papers/paper-bertotti-xenopatients-her2-cetuximab-resistant-colorectal-cancer-discov-2011/"},{"id":"paper-adusumilli-cancer-discov","kind":"paper","name":"A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab","route":"/key-papers/paper-adusumilli-cancer-discov/"},{"id":"paper-martini-african-ancestry-tnbc-cancer-discov-2022","kind":"paper","name":"African ancestry-associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent","route":"/key-papers/paper-martini-african-ancestry-tnbc-cancer-discov-2022/"},{"id":"paper-quigley-brca2-reversion-cfdna-parp-resistance-cancer-discov-2017","kind":"paper","name":"Analysis of circulating cell-free DNA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors","route":"/key-papers/paper-quigley-brca2-reversion-cfdna-parp-resistance-cancer-discov-2017/"},{"id":"paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021","kind":"paper","name":"Atezolizumab plus bevacizumab in advanced malignant peritoneal mesothelioma","route":"/key-papers/paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021/"},{"id":"paper-friedman-cancer-discov","kind":"paper","name":"Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study","route":"/key-papers/paper-friedman-cancer-discov/"},{"id":"paper-fernandez-cuesta-cd74-nrg1-fusion-lung-cancer-discov-2014","kind":"paper","name":"CD74-NRG1 fusions in lung adenocarcinoma","route":"/key-papers/paper-fernandez-cuesta-cd74-nrg1-fusion-lung-cancer-discov-2014/"},{"id":"paper-demaria-cancer-discov","kind":"paper","name":"Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse","route":"/key-papers/paper-demaria-cancer-discov/"},{"id":"paper-chmielecki-acinar-cell-carcinoma-raf-fusions-dna-repair-cancer-discov-2014","kind":"paper","name":"Chmielecki 2014: comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes","route":"/key-papers/paper-chmielecki-acinar-cell-carcinoma-raf-fusions-dna-repair-cancer-discov-2014/"},{"id":"paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018","kind":"paper","name":"Circulating tumour DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer","route":"/key-papers/paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018/"},{"id":"paper-skoulidis-kras-co-mutation-subsets-cancer-discov-2015","kind":"paper","name":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","route":"/key-papers/paper-skoulidis-kras-co-mutation-subsets-cancer-discov-2015/"},{"id":"paper-elyada-antigen-presenting-cafs-single-cell-cancer-discov-2019","kind":"paper","name":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","route":"/key-papers/paper-elyada-antigen-presenting-cafs-single-cell-cancer-discov-2019/"},{"id":"paper-dudley-cancer-discov","kind":"paper","name":"Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA","route":"/key-papers/paper-dudley-cancer-discov/"},{"id":"paper-stoeck-notch-rearrangements-tnbc-cancer-discov-2014","kind":"paper","name":"Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma","route":"/key-papers/paper-stoeck-notch-rearrangements-tnbc-cancer-discov-2014/"},{"id":"paper-kornauth-cancer-discov","kind":"paper","name":"Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders","route":"/key-papers/paper-kornauth-cancer-discov/"},{"id":"paper-grasso-immune-evasion-colorectal-cancer-discov-2018","kind":"paper","name":"Genetic mechanisms of immune evasion in colorectal cancer","route":"/key-papers/paper-grasso-immune-evasion-colorectal-cancer-discov-2018/"},{"id":"paper-hallmarks-new-dimensions-cancer-discov-2022","kind":"paper","name":"Hallmarks of Cancer 2022: adding phenotypic plasticity, epigenetic reprogramming, microbiomes and senescent cells","route":"/key-papers/paper-hallmarks-new-dimensions-cancer-discov-2022/"},{"id":"paper-heining-nrg1-fusions-kras-wild-type-pancreatic-cancer-discov-2018","kind":"paper","name":"Heining 2018: NRG1 fusions in KRAS wild-type pancreatic cancer","route":"/key-papers/paper-heining-nrg1-fusions-kras-wild-type-pancreatic-cancer-discov-2018/"},{"id":"paper-raajit-rampal-cancer-discov-2015","kind":"paper","name":"JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","route":"/key-papers/paper-raajit-rampal-cancer-discov-2015/"},{"id":"paper-mesothelin-mesothelioma-cancer-discov-2016","kind":"paper","name":"Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors","route":"/key-papers/paper-mesothelin-mesothelioma-cancer-discov-2016/"},{"id":"paper-frampton-met-exon-14-cancer-discov-2015","kind":"paper","name":"MET exon 14 splicing alterations across tumour types and their sensitivity to MET inhibitors","route":"/key-papers/paper-frampton-met-exon-14-cancer-discov-2015/"},{"id":"paper-beltran-nepc-aurka-mycn-cancer-discov-2011","kind":"paper","name":"Molecular characterisation of neuroendocrine prostate cancer and identification of new drug targets","route":"/key-papers/paper-beltran-nepc-aurka-mycn-cancer-discov-2011/"},{"id":"paper-gainor-alk-resistance-mutations-cancer-discov-2016","kind":"paper","name":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","route":"/key-papers/paper-gainor-alk-resistance-mutations-cancer-discov-2016/"},{"id":"paper-engstrom-cancer-discov","kind":"paper","name":"MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer","route":"/key-papers/paper-engstrom-cancer-discov/"},{"id":"paper-dangelo-ny-eso-1-tcr-synovial-sarcoma-cancer-discov-2018","kind":"paper","name":"NY-ESO-1 c259 T-cell receptor therapy in synovial sarcoma: prolonged persistence and antitumour activity","route":"/key-papers/paper-dangelo-ny-eso-1-tcr-synovial-sarcoma-cancer-discov-2018/"},{"id":"paper-tiriac-cancer-discov","kind":"paper","name":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","route":"/key-papers/paper-tiriac-cancer-discov/"},{"id":"paper-jordan-prospective-lung-adenocarcinoma-msk-cancer-discov-2017","kind":"paper","name":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","route":"/key-papers/paper-jordan-prospective-lung-adenocarcinoma-msk-cancer-discov-2017/"},{"id":"paper-aguirre-real-time-genomic-characterisation-pancreatic-cancer-discov-2018","kind":"paper","name":"Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine","route":"/key-papers/paper-aguirre-real-time-genomic-characterisation-pancreatic-cancer-discov-2018/"},{"id":"paper-kras-nsclc-cancer-discov-2018","kind":"paper","name":"STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma","route":"/key-papers/paper-kras-nsclc-cancer-discov-2018/"},{"id":"paper-roberts-familial-pancreatic-whole-genome-cancer-discov-2016","kind":"paper","name":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","route":"/key-papers/paper-roberts-familial-pancreatic-whole-genome-cancer-discov-2016/"}],"person":[{"id":"paul-boutros","kind":"person","name":"Paul Boutros","route":"/people/paul-boutros/"},{"id":"robert-winn","kind":"person","name":"Robert A. Winn","route":"/people/robert-winn/"},{"id":"shivaani-kummar","kind":"person","name":"Shivaani Kummar","route":"/people/shivaani-kummar/"}]}}